Evidence map›Paper›PMID 40881814›Full record

ArticleMediterranean journal of rheumatology2025

A Clinical Case Report of Deficiency of Adenosine Deaminase 2 Syndrome (DADA 2) Presenting as a Brachial Artery Aneurysm.

Shama Sowdagar, Avanish Jha, Prabhu Vasanth, John Mathew

Abstract readCase Reports
In one paragraph

Article in Mediterranean journal of rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shama SowdagarDepartment of Clinical Immunology and Rheumatology, Christian Medical College, Vellore, Tamil Nadu, India.
Avanish JhaDepartment of Clinical Immunology and Rheumatology, Christian Medical College, Vellore, Tamil Nadu, India.
Prabhu VasanthDepartment of Clinical Immunology and Rheumatology, Christian Medical College, Vellore, Tamil Nadu, India.
John MathewDepartment of Clinical Immunology and Rheumatology, Christian Medical College, Vellore, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Deficiency of adenosine deaminase 2 (DADA 2) syndrome is a monogenic auto-inflammatory vasculitic syndrome caused by loss of function mutations in the ADA2 gene. Disease manifestations are divided into three major phenotypes: inflammatory/vascular, immune dysregulation, and haematologic, with majority having significant overlap between these phenotypes. The disease has undergone extensive phenotypic expansion since its first description in 2014. It is autosomal recessively inherited and commonly presents with fever, recurrent strokes, livedo racemosa, and polyarteritis nodosa (PAN)-like features. Though the disease has its symptom onset early in childhood, various case series have described patients with symptom onset in adulthood. Visceral arterial aneurysms as a manifestation have been described in literature but not peripheral aneurysms. Here, we describe a young adult with DADA 2 syndrome presenting with peripheral arterial aneurysm involving the brachial artery. Case report: Patient had recurrent episodes of CVA since childhood, a history of orchitis, systemic hypertension, and new onset brachial artery aneurysm at the age of twenty-three. Diagnosis was confirmed by genetic analysis. Tumour necrosis factor inhibitors (TNFi) have emerged as the drug of choice for the treatment of DADA2 and studies revealed a drastic reduction in stroke risk after initiation of TNFi. Based on this experience, we have started the patient on adalimumab, and he is doing well for the past one year. Conclusion: Peripheral artery aneurysm can be a manifestation of vasculitis in DADA 2 syndrome.

Indexed as

brachial arteryDADA 2 syndromeperipheral arterial aneurysmpolyarteritis nodosavasculitis

Identifiers

PMID40881814
PMCPMC12183452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.